Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics
WVE Stock Summary
- Of note is the ratio of Wave Life Sciences Ltd's sales and general administrative expense to its total operating expenses; just 11.3% of US stocks have a lower such ratio.
- With a price/sales ratio of 49.08, Wave Life Sciences Ltd has a higher such ratio than 97.18% of stocks in our set.
- Revenue growth over the past 12 months for Wave Life Sciences Ltd comes in at 116.88%, a number that bests 95.27% of the US stocks we're tracking.
- Stocks that are quantitatively similar to WVE, based on their financial statements, market capitalization, and price volatility, are RCUS, ORMP, MRSN, KALV, and AGIO.
- Visit WVE's SEC page to see the company's official filings. To visit the company's web site, go to www.wavelifesciences.com.
WVE Stock Price Chart More Charts
WVE Price/Volume Stats
Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.